About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

NEURESCUE Device as an Adjunct to Cardiac Arrest | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT05146661

NEURESCUE Device as an Adjunct to Cardiac Arrest

The NEURESCUE device is the first intelligent balloon catheter for aortic occlusion, an emergency technique that supercharges blood flow to the heart and brain within one minute from deployment. The ...

Lead sponsor: neurescue•2 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Sponsors

Lead Sponsor

neurescue

Age

18 - 79 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•1. Age ≥18 and ≤79 years
•2. Witnessed cardiac arrest
•3. CPR initiated within 7 min of presumed arrest
•4. Cardiac arrest not responding to standard ALS
•5. Total CPR time ≤ 40 min at the time of screening for enrollment

Exclusion Criteria

•1. Traumatic cardiac arrest
•2. Known pregnancy
•3. Known terminal disease
•4. Known Do-Not-Resuscitate (DNR) order
•5. Subjects whose femoral arterial access site cannot accommodate an 8 Fr introducer sheath
•6. Subjects currently on mechanical circulatory support

Related studies

Study on Construction of Whole Lifecycle Cohort, Big Data Management and Clinical Prognosis of Cardio-Renal-Metabolic (CKM) Syndrome

NCT07547098 · Cardiovascular Diseases (CVD), Chronic Kidney Disease, and more

Neuroprotective Effect of Remote Ischemic Post-conditioning in Out-of-hospital Cardiac Arrest

NCT06473207 · Out-Of-Hospital Cardiac Arrest

intErnet-based iNterventions FOR Cardiac arrEst suRvivors

NCT06395558 · Cognitive Impairment, Depression, Anxiety, and more

Study of the Occurrence of Cardiocirculatory Arrest as a Function of the Level of Hypoxemia During a Maastricht 3 Procedure

NCT06780722 · Cardiac Arrest, Reanimation

Is Post-exertional Symptom Exacerbation Specific to Patients With Myalgic Encephalomyelitis / Chronic Fatigue Syndrome? A Study Comparing Patients With Myalgic Encephalomyelitis / Chronic Fatigue Syndrome and Patients With Cardiac Diseases Who Underwent an Exercise Test.

NCT07491315 · Fatigue Syndrome, Chronic, Cardiovascular Diseases

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 5, 2024Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment10

Start dateAug 2022

Last updatedJan 5, 2024

Condition

Cardiac Arrest Cardiopulmonary Arrest Cardiovascular Diseases

Locations shown

Charité - Universitätsklinikum Berlin

Berlin

Universitätsklinikum Heidelberg

Heidelberg

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 5, 2024Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions